A Resource for Healthcare and Social Services Professionals
September 2, 2020
12:15 pm–1:00 pm ET
This one-hour training prepares nurses and other medical professionals to use monthly injectable buprenorphine (Sublocade) in addiction treatment.
Via Zoom
Visit the meeting URL
This is a one-hour training that prepares nurses offering medication for opioid-use disorder to manage addiction treatment with monthly injectable buprenorphine. Topics covered will include: the pharmacology of monthly injectable buprenorphine; patient selection; medication storage and administration; clinical logistics; side effects; supplemental dosing; lessons learned from the field; and billing and specialty pharmacies. We will also have an open discussion to learn from each other’s experiences with using this treatment.
This training will be held via Zoom. We would prefer that you log in using a computer with a web cam so that we can all connect to each other via video. Please note that signing on with video is required to receive CEs. If you do not have access to a web cam, please let us know. The document on this page (the "event flyer") will walk you through how to connect to a Zoom meeting from your computer for the first time.
Attendance is required for all OBAT nurses and MAs who work in a DPH/BSAS funded STATE OBOT program. All others working with patients on injectable buprenorphine are welcome and encouraged to attend. This training is meant for health workers at Manet Community Health Center.
Andrea is a Nurse Practitioner and Clinical Educator for the OBAT TTA Program at Boston Medical Center with clinical interest and expertise in women’s health, individuals experiencing homelessness, and chronic disease management. She is committed to serving vulnerable populations and works per diem at Boston Health Care for the Homeless Program; Andrea has also conducted international healthcare work in Haiti. She is a term lecturer and preceptor for nurse practitioner students at the MGH Institute of Health Professions (MGH IHP). Andrea received her Masters of Science in Nursing in 2011 and her Doctorate of Nursing Practice in 2018, both from the MGH IHP. She is board certified in addictions nursing through the Addictions Nursing Certification Board.
The learner will: understand the pharmacology, side effects, and supplemental dosing of injectable buprenorphine; learn about the related billing and specialty pharmacy protocols; and participate in an open discussion with those who have implemeneted Sublocade in their practices to learn from their experiences.
Boston Medical Center Grayken Center for Addiction, Department of Public Health, Bureau of Addiction Services
Boston Medical Center grants 1.00 hours to all nurses who attend, complete the evaluation, and complete the post test. Boston Medical Center is approved as a provider of continuing professional development by American Nurses Association, Massachusetts, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.
The content on this site and the content presented by Grayken Center for Addiction TTA is intended solely to inform and educate healthcare and social service professionals, and shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional. The hospital, the program, and the contributors are not acting as health care providers or professional consultants on behalf of any specific patient and disclaim establishing a provider-patient relationship with any specific patient.